Soligenix's (NASDAQ:SNGX) Breakthrough Therapies for Rare Diseases – Corporate Update

Soligenix; Deadly Marburg Virus Outbreak Highlights the Need for MarVax™ Vaccine

Soligenix; Discussing the Benefits of HyBryte™ CTCL Treatment with Michael W. Young

Soligenix; Importance of the Proposed Reverse Stock Split

Soligenix; Initiating Phase 2 Clinical Trial of SGX302 in Mild to Moderate Psoriasis

Soligenix; Announcing New FDA Drug Application Submission for Cutaneous T-cell Lymphoma

President & CEO Chris Schaber Sits Down with New To The Street to Talk about the Company

Soligenix; Announcing Formation of Psoriasis Medical Advisory Board

Soligenix; Discussing Psoriasis Treatment with Dr. Neal Bhatia

Soligenix ; FDA Awards $2.6 Million Orphan Products Development Grant for Expanded Study of HyBryte™

Soligenix; HyBryte™ Phase 3 FLASH Study Published in JAMA Dermatology

Soligenix; FDA IND Clearance Received for Phase 2 Trial of Synthetic Hypericin

Soligenix Investor Overview

Soligenix; Announcing Successful Protection Using a Bivalent Thermostabilized Filovirus Vaccine

Soligenix; Diving into Photodynamic Therapy Safety & Hybryte Treatment with Dr. Ellen Kim.

Soligenix; Diving into HyBryte CTCL Treatment Efficacy and Safety with Dr. Jennifer DeSimone

Soligenix; Diving into Dusquetide with Chief Scientific Officer Oreola Donini

Soligenix; Receives US Patent Allowance for Thermal Stabilized Vaccine Platform

Soligenix; Discussing Cutaneous Lymphoma with Foundation CEO Susan Thornton

Soligenix; Cutaneous Lymphoma Foundation CEO Susan Thornton on HyBryte™

Soligenix; An Introduction to Senior Vice President and CFO Jonathan Guarino

Soligenix; Heat Stable COVID 19 Vaccine Neutralizing Against Delta and Omicron in Non Human Primates

Soligenix; An Introduction to Chief Scientific Officer Dr. Oreola Donini

Soligenix; An Introduction to Christopher J. Schaber

Soligenix; Diving Deeper Into The Company Itself

Soligenix - U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma

SGX942 innate immunity

SGX942 Pathobiology of Mucositis animation

Soligenix T Cell Animation

Review of IDR Mechanism of Action and Potential Therapeutic Applications, November 26, 2018